Huang S, Ma S, Ning M, Yang W, Ye Y, Zhang L, et al
The company built its proprietary Precision Endocrine Peptide (PEP) platform to engineer peptide hormones with extended time-action profiles, aiming to overcome the dosing-frequency and tolerability limitations of earlier peptide therapeutics, including in the obesity space
The FDA has taken formal steps to restrict or eliminate large-scale outsourcing compounding of these drug classes, and the regulatory picture remains in active development at the time this article was written
Theyre not mentally negotiating all day
This is where GLP-1 medications may play a role
How to Choose Quality Supplements for GLP-1 Medications Not all supplements are designed with reduced appetite, smaller meals, or changing digestion patterns in mind